The University of Manitoba (UM) in partnership with the Universities of Alberta, Saskatchewan and Calgary, has received $57 million in critical funding to conduct world-leading vaccine and biomanufacturing research and build two new innovative facilities, an investment that positions the institution to play a significant role in addressing future pandemic threats in Canada and around the world.